#South Korea #Seoul #Seegene #CURECA #PCR Automation

Seegene's CURECA System: A Game Changer in PCR Automation

Seegene Inc., a leader in molecular diagnostics, has made headlines at the ESCMID Global 2025 conference in Vienna with the introduction of their innovative CURECA system. This fully modular automation solution aims to significantly advance the process of PCR testing by automating pre-processing and analysis of various sample types.

The Vision Behind CURECA

The launch of CURECA is driven by the necessity for efficient, hands-free workflows in laboratory environments. As laboratories face increasing workloads and the complexity of sample preparation, the CURECA system aims to minimize manual errors associated with traditional processes. This is crucial for achieving fast and reliable diagnostic results, particularly in the face of ongoing public health challenges.

The system was showcased in a concept video that attracted significant interest, with over 2,300 attendees viewing the presentation. Notable professionals from countries such as Italy, Spain, Germany, France, and Canada expressed excitement over the potential of CURECA to revolutionize PCR diagnostics. According to experts, CURECA not only aims to reduce human error but also increases testing capacity without being constrained by labor availability.

Key Components of the CURECA System

CURECA's foundation lies in three main systems:
1. Customizable Pre-treatment System (CPS): This module automates the insertion of sample tubes and their pre-processing. It is designed for various diagnostic fields including molecular diagnostics, clinical chemistry, and immunology. Young-Seag Baeg, Seegene's head of strategy and planning, highlighted its significance in streamlining testing procedures.
2. Primary Sample Aliquot System (PAS): For cases that do not require pre-processing, this system simplifies the workflow by allowing direct insertion and aliquoting of primary samples.
3. Customizable Expandable Full Automation (CEFA): This modular solution provides the flexibility to cover diverse laboratory needs.

Experts have noted that CURECA could drastically improve turnaround times (TAT) for tests, especially in high-demand scenarios like sexually transmitted infection (STI) testing, where sample handling can be cumbersome at present. By significantly reducing time-consuming manual processes, the system holds promise for enhancing lab efficiency and worker satisfaction.

Immediate Implications for the Lab Community

The CURECA system has captured the attention of laboratory professionals eager to adopt this next step in diagnostic automation. During the ESCMID Global 2025, feedback from attendees indicated a strong desire to incorporate CURECA, particularly for reducing operational burdens linked with manual sample management. Many expressed that a fully automated approach would enable laboratories to dedicate more time to analysis rather than preparation.

"The flexibility of the CURECA system allows us to implement workflows that yield high-quality results with minimal dependence on standardized lab configurations," shared one conference participant.

Moreover, the modular nature of CURECA facilitates customization for laboratories working with different test types and volumes, making it adaptable and scalable.

Looking Ahead

As Seegene prepares for the commercial launch of CURECA in July 2025, the diagnostic community waits with anticipation. Jong-Yoon Chun, Seegene's CEO, emphasized the global demand for next-generation diagnostic solutions, hoping that the CURECA system can lead a major transformation in PCR diagnostics worldwide. Many industry experts are eager for the opportunity to view the system firsthand, with plans for a demonstration at the upcoming ADLM 2025 conference in Chicago.

In conclusion, the CURECA system from Seegene promises to not only enhance the efficiency and accuracy of PCR testing but also pave the way for more advanced, fully automated laboratories that can meet modern healthcare demands.